EcoDrugPlus

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSPCTG00005013234
Gene Symbol: AVPR1A
1 Cross references
264 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSPCTG00005021602
Gene Symbol: AVPR2
1 Cross references
231 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSPCTG00005010575
Gene Symbol: LOC102982657
3 Cross references
307 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSPCTG00005012853
Gene Symbol: AURKB
3 Cross references
202 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPCTG00005020776
Gene Symbol: BDKRB2
3 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSPCTG00005000588
Gene Symbol: BCHE
1 Cross references
130 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSPCTG00005007486
Gene Symbol: CASR
3 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSPCTG00005007342
Gene Symbol: CACNA2D2
1 Cross references
272 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSPCTG00005022214
Gene Symbol: CACNA2D3
1 Cross references
307 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSPCTG00005003713
Gene Symbol: CACNA2D4
1 Cross references
317 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 1

Ensembl ID : ENSPCTG00005006622
Gene Symbol: CACNB1
1 Cross references
209 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2

Ensembl ID : ENSPCTG00005003907
Gene Symbol: CACNB2
3 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).